Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Invitrogen™ Cyclin L2 Polyclonal Antibody

Rabbit Polyclonal Antibody

Supplier:  Invitrogen™ PA5100708

Catalog No. PIPA5100708


Only null left
Add to Cart

Description

Description

Antibody detects endogenous levels of total CCNL2.

CCNL2 belongs to the cyclin family, Cyclin L subfamily. CCNL2 is a transcriptional regulator which participates in regulating the pre-mRNA splicing process. CCNL2 also modulates the expression of critical apoptotic factor, leading to cell apoptosis.
TRUSTED_SUSTAINABILITY
Specifications

Specifications

Cyclin L2
Polyclonal
Unconjugated
CCNL2
1700010A01Rik; 1810019L15Rik; 2010319M22Rik; AA409936; Ania6b; ANIA-6B; AW261738; Ccnl2; CCNM; CCNS; Cyclin Ania-6b; cyclin L2; cyclin M; cyclin S; cyclin-L2; HCLA-150; HCLA-ISO; HLA-ISO; hypothetical protein LOC538796; MNCb-5160; paneth cell enhanced expression; paneth cell-enhanced expression protein; PCEE; SB138
Rabbit
Affinity chromatography
RUO
298686, 56036, 81669
-20°C
Liquid
Western Blot
1 mg/mL
PBS with 50% glycerol and 0.02% sodium azide; pH 7.4
Q5I0H5, Q96S94, Q9JJA7
CCNL2
A synthesized peptide derived from human CCNL2(Accession Q96S94), corresponding to amino acid residues K485-R520.
100 μL
Primary
Human, Mouse, Rat
Antibody
IgG
Product Suggestions

Product Suggestions

Videos
Safety and Handling

Safety and Handling

WARNING: Cancer - www.P65Warnings.ca.gov
SDS
Documents

Documents

Product Certifications
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.